Advances in Treatment Options for Children and Adolescents with Type 2 Diabetes Mellitus Evaluation (ID: i756a) Survey

Question Title

* 1. After participating in this activity, how confident are you in the management of patients with T2DM in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 2. What is your degree?

MD/DO

Other (please specify)

Question Title

* 3. How many years have you been in practice?

>21

11-20

1-10

Question Title

* 4. How many patients with T2DM do you manage?

1 to 25

26 to 50

51 to 100

100+

I am not directly involved in patient care

Question Title

* 5. Please select the option that best describes your practice setting:

Academic medical center

Community hospital or medical center

Other (please specify)

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I change my practice behavior

This activity will not change my practice, as my current practice is consistent with the information presented

This activity will not change my practice

Question Title

* 7. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

Question Title

* 8. As a result of your participation in this activity, what is one change you are most likely to implement in your practice?

Question Title

* 9. What barriers do you see to making changes in your practice?

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement, or legal issues

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 10. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 11. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Describe the increasing prevalence of T2DM among children and adolescents, along with evidence-based screening and diagnostic recommendations to identify at-risk youth	Describe the increasing prevalence of T2DM among children and adolescents, along with evidence-based screening and diagnostic recommendations to identify at-risk youth Strongly agree	Describe the increasing prevalence of T2DM among children and adolescents, along with evidence-based screening and diagnostic recommendations to identify at-risk youth Agree	Describe the increasing prevalence of T2DM among children and adolescents, along with evidence-based screening and diagnostic recommendations to identify at-risk youth Neutral	Describe the increasing prevalence of T2DM among children and adolescents, along with evidence-based screening and diagnostic recommendations to identify at-risk youth Disagree	Describe the increasing prevalence of T2DM among children and adolescents, along with evidence-based screening and diagnostic recommendations to identify at-risk youth Strongly disagree
Integrate guideline-directed strategies into routine management of children and adolescents with T2DM	Integrate guideline-directed strategies into routine management of children and adolescents with T2DM Strongly agree	Integrate guideline-directed strategies into routine management of children and adolescents with T2DM Agree	Integrate guideline-directed strategies into routine management of children and adolescents with T2DM Neutral	Integrate guideline-directed strategies into routine management of children and adolescents with T2DM Disagree	Integrate guideline-directed strategies into routine management of children and adolescents with T2DM Strongly disagree
Review efficacy and safety outcomes, mechanisms of action, and prescribing information on newly approved and emerging therapies for pediatric patients with T2DM	Review efficacy and safety outcomes, mechanisms of action, and prescribing information on newly approved and emerging therapies for pediatric patients with T2DM Strongly agree	Review efficacy and safety outcomes, mechanisms of action, and prescribing information on newly approved and emerging therapies for pediatric patients with T2DM Agree	Review efficacy and safety outcomes, mechanisms of action, and prescribing information on newly approved and emerging therapies for pediatric patients with T2DM Neutral	Review efficacy and safety outcomes, mechanisms of action, and prescribing information on newly approved and emerging therapies for pediatric patients with T2DM Disagree	Review efficacy and safety outcomes, mechanisms of action, and prescribing information on newly approved and emerging therapies for pediatric patients with T2DM Strongly disagree
Apply effective communications strategies involving shared decision-making with the pediatric patient and family to achieve lifestyle changes and foster medication adherence	Apply effective communications strategies involving shared decision-making with the pediatric patient and family to achieve lifestyle changes and foster medication adherence Strongly agree	Apply effective communications strategies involving shared decision-making with the pediatric patient and family to achieve lifestyle changes and foster medication adherence Agree	Apply effective communications strategies involving shared decision-making with the pediatric patient and family to achieve lifestyle changes and foster medication adherence Neutral	Apply effective communications strategies involving shared decision-making with the pediatric patient and family to achieve lifestyle changes and foster medication adherence Disagree	Apply effective communications strategies involving shared decision-making with the pediatric patient and family to achieve lifestyle changes and foster medication adherence Strongly disagree

Question Title

* 12. Amy Sanghavi Shah, MD, MS, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 13. Charles Vega, MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 14. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 1. After participating in this activity, how confident are you in the management of patients with T2DM in your practice?

Question Title

* 2. What is your degree?

Question Title

* 3. How many years have you been in practice?

Question Title

* 4. How many patients with T2DM do you manage?

Question Title

* 5. Please select the option that best describes your practice setting:

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

Question Title

* 7. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 8. As a result of your participation in this activity, what is one change you are most likely to implement in your practice?

Question Title

* 9. What barriers do you see to making changes in your practice?

Question Title

* 10. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 11. After participating in today’s activity, I am now able to:

Question Title

* 12. Amy Sanghavi Shah, MD, MS, effectively:

Question Title

* 13. Charles Vega, MD, effectively:

Question Title

* 14. The content presented:

Question Title

* 15. If you indicated that you perceived commercial bias or influence, please describe: